Luca Malcovati
Reproducibility track record
1
assessed papers
60/100
mean reproducibility
0
reproduced (C1–C2)
0
flagged
10
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
Funders
—
Frequent co-authors
Gabriele Todisco 1Juan P. Romero 1Jin Ye 1Isabel A. Calvo 1Borja Sáez 1Amaia Vilas‐Zornoza 1Ignacio Sancho 1David Gómez-Cabrero 1Miren Lasaga 1Itziar Cenzano 1
Institutions
King Abdullah University of Science and Technology 1Navarre Institute of Health Research 1Centro de Investigación Biomédica en Red de Cáncer 1Universidad de Navarra 1Universidad Publica de Navarra 1Complejo Hospitalario de Navarra 1
Geography (author institutions)
SA 1ES 1IT 1SE 1GB 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (689)
Request a reproduction →1 assessed by us (0 reproduced) · 688 not yet assessed — every PubMed paper on record, linked below.
-
Evolutionary trajectories of myelodysplastic syndromes/neoplasms ↗Seminars in Cancer Biology · 2026 · PMID 41651099not yet assessed
-
Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review and meta-analysis ↗Blood Advances · 2026 · PMID 41538293not yet assessed
-
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study ↗Journal of Hematology & Oncology · 2026 · PMID 42363232not yet assessed
-
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies ↗British Journal of Haematology · 2026 · PMID 41704134not yet assessed
-
Characterization and Outcomes of Patients with Systemic Mastocytosis with Associated Lymphoid Neoplasms: An ECNM-CEREMAST Study ↗SSRN Electronic Journal · 2026not yet assessed
-
Response to Comment on: “Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm.” ↗Haematologica · 2026 · PMID 42163773not yet assessed
-
Initial leukemic epigenomic state determines hypomethylating agent response ↗Nature Communications · 2026 · PMID 42173855not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis ↗Blood Neoplasia · 2026 · PMID 42571225not yet assessed
-
Inflammatory signatures in the spectrum of myeloid diseases ↗HemaSphere · 2026 · PMID 42416330not yet assessed
-
The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes ↗eJHaem · 2026 · PMID 42529759not yet assessed
-
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis ↗Experimental Hematology and Oncology · 2026 · PMID 42625226not yet assessed
-
not yet assessed
-
not yet assessed
-
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT ↗Blood · 2025 · PMID 39970324not yet assessed
-
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet ↗The Lancet Haematology · 2025 · PMID 39909657not yet assessed
-
American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults ↗Blood Advances · 2025 · PMID 41321225not yet assessed
-
Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT ↗Blood · 2025 · PMID 40106773not yet assessed
-
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndrome ↗Leukemia Research · 2025 · PMID 40651101not yet assessed
-
Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes ↗Blood Advances · 2025 · PMID 40188457not yet assessed
-
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery ↗Blood · 2025 · PMID 40758958not yet assessed
-
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study ↗The Lancet Haematology · 2025 · PMID 39909656not yet assessed
-
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States ↗Blood Cancer Discovery · 2025 · PMID 40608896not yet assessed
-
CHEK2 Germline Variants in Early‐Onset and Familial Myeloproliferative Neoplasms ↗American Journal of Hematology · 2025 · PMID 40926526not yet assessed
-
In vitro studies of human erythropoiesis using a 3D silk-based bone marrow model that generates erythroblastic islands ↗Blood Advances · 2025 · PMID 39951616not yet assessed
-
Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower‐risk myelodysplastic syndromes ↗HemaSphere · 2025 · PMID 39850648not yet assessed
-
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial ↗Blood Advances · 2025 · PMID 39808795not yet assessed
-
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS Registry ↗Haematologica · 2025 · PMID 40207727not yet assessed
-
not yet assessed
-
Clonal megakaryocyte dysplasia with normal blood values (CMD-NBV): an unique form of early myeloproliferative neoplasm ↗Research Square · 2025not yet assessed
-
Warfarin reduces circulating white blood cell count: Post-hoc analysis of two randomized trials ↗Thrombosis Research · 2025 · PMID 40925065not yet assessed
-
A COMPARISON OF PROGNOSTIC VARIABLES AND CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED AND 4738 WITH PRIMARY MDS INCLUDING THE INFLUENCE OF TREATMENT IN MDS-PHASE ↗Leukemia Research · 2025not yet assessed
-
PARALLEL SESSION 02: CLONAL DISORDERS CLOSELY RELATED MDS ↗Leukemia Research · 2025not yet assessed
-
PROGNOSIS - PROGNOSTIC FACTORS OF OUTCOME AND RISK ASSESSMENT ↗Leukemia Research · 2025not yet assessed
-
Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational Data ↗Medical Decision Making · 2025 · PMID 41143386not yet assessed
-
Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm ↗Haematologica · 2025 · PMID 41262049not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Molecular taxonomy of myelodysplastic syndromes and its clinical implications ↗Blood · 2024 · PMID 38958467not yet assessed
-
Molecular and clinical presentation of UBA1 -mutated myelodysplastic syndromes ↗Blood · 2024 · PMID 38687605not yet assessed
-
Risk prediction for clonal cytopenia: multicenter real-world evidence ↗Blood · 2024 · PMID 38996210not yet assessed
-
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry ↗Allergy · 2024 · PMID 38651829not yet assessed
-
Mis-splicing of Mitotic Regulators Sensitizes SF3B1-Mutated Human HSCs to CHK1 Inhibition ↗Blood Cancer Discovery · 2024 · PMID 38856693not yet assessed
-
How I manage patients with unexplained cytopenia ↗Blood · 2024 · PMID 39786421not yet assessed
-
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM ↗Blood Advances · 2024 · PMID 38593217not yet assessed
-
Genome sequencing in the management of myelodysplastic syndromes and related disorders ↗Haematologica · 2024 · PMID 39445412not yet assessed
-
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS‐M) prediction in myelodysplastic syndromes ↗Journal of Internal Medicine · 2024 · PMID 38654517not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Navigating the misty lands of monocytosis ↗Blood · 2024 · PMID 38512267not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
iPSC Reprogramming Identifies the Role of Cryptic Drivers in Preleukemic Clonal Evolution ↗Blood · 2024not yet assessed
-
3D Silk-Based Bone Marrow Models Identify Autophagy As a Critical Mechanism in Red Blood Cell Production ↗Blood · 2024not yet assessed
-
not yet assessed
-
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis ↗NEJM Evidence · 2023 · PMID 37483562not yet assessed
-
Multiparameter prediction of myeloid neoplasia risk ↗Nature Genetics · 2023 · PMID 37620601not yet assessed
-
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes ↗Blood · 2023 · PMID 36724453not yet assessed
-
Diagnosis and classification of myelodysplastic syndromes ↗Blood · 2023 · PMID 37774372not yet assessed
-
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1 , GATA2 , and DDX41 ↗Blood Advances · 2023 · PMID 37406166not yet assessed
-
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0 ↗Annals of Oncology · 2023 · PMID 37343663not yet assessed
-
Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity ↗Blood · 2023 · PMID 37216690not yet assessed
-
IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation ↗Blood Cancer Discovery · 2023 · PMID 38091010not yet assessed
-
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring Sideroblasts ↗Clinical Cancer Research · 2023 · PMID 37498312not yet assessed
-
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study ↗Blood Advances · 2023 · PMID 36607832not yet assessed
-
VEXAS: walking on the edge of malignancy ↗Blood · 2023 · PMID 37471107not yet assessed
-
Author Correction: Pan-cancer analysis of whole genomes ↗Nature · 2023 · PMID 36697834not yet assessed
-
Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes ↗Nature · 2023 · PMID 36697832not yet assessed
-
Author Correction: The repertoire of mutational signatures in human cancer ↗Nature · 2023 · PMID 36697836not yet assessed
-
not yet assessed
-
Author Correction: Patterns of somatic structural variation in human cancer genomes ↗Nature · 2023 · PMID 36697835not yet assessed
-
Author Correction: The evolutionary history of 2,658 cancers ↗Nature · 2023 · PMID 36697833not yet assessed
-
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing ↗Nature Genetics · 2023 · PMID 36944733not yet assessed
-
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition ↗Nature Genetics · 2023 · PMID 36944736not yet assessed
-
Mitotic Dysregulation Sensitizes Malignant Stem Cells to CHK1 Inhibition in SF3B1-Mutant Myeloid Neoplasms ↗Blood · 2023not yet assessed
-
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers ↗Nature Genetics · 2023 · PMID 36944732not yet assessed
-
Author Correction: Genomic basis for RNA alterations in cancer ↗Nature · 2023 · PMID 36697831not yet assessed
-
Author Correction: The landscape of viral associations in human cancers ↗Nature Genetics · 2023 · PMID 36944734not yet assessed
-
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer ↗Nature Genetics · 2023 · PMID 36944735not yet assessed
-
Author Correction: Multiparameter prediction of myeloid neoplasia risk ↗Nature Genetics · 2023 · PMID 37726541not yet assessed
-
not yet assessed
-
not yet assessed
-
Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes ↗Nature Biotechnology · 2023 · PMID 36944844not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 6168: Implementation and adoption of a web tool to support precision diagnostic and treatment decisions for patient with myelodysplastic syndromes ↗Cancer Research · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Topic: AS01-Diagnosis/AS01a-Cytomorphology: AUTOMATED DIGITAL TOOL FOR MDS AND MDS/MPN CLASSIFICATION USING WHO AND ICC: INTERNATIONAL GUIDELINES WORKING GROUP ON MDS DIAGNOSIS, PROGNOSIS, AND GERMLINE PREDISPOSITION ↗Leukemia Research · 2023not yet assessed
-
CCUS: CLINICAL PERSPECTIVE (HIGH-RISK CCUS) ↗Leukemia Research · 2023not yet assessed
-
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): GENOMIC CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES ↗Leukemia Research · 2023not yet assessed
-
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE ↗Leukemia Research · 2023not yet assessed
-
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS) ↗Leukemia Research · 2023not yet assessed
-
P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION ↗HemaSphere · 2023not yet assessed
-
PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0 ↗HemaSphere · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
The Significance of Variant Allele Frequency in SF3B1 Mutated Myelodysplastic Neoplasms/Syndromes ↗Blood · 2023not yet assessed
-
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data ↗Blood · 2022 · PMID 35767897not yet assessed
-
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes ↗NEJM Evidence · 2022 · PMID 38319256not yet assessed
-
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia ↗Blood · 2022 · PMID 36130297not yet assessed
-
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms ↗Blood · 2022 · PMID 36322930not yet assessed
-
Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome ↗Nature Cell Biology · 2022 · PMID 35292784not yet assessed
-
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry ↗Blood Advances · 2022 · PMID 36094848not yet assessed
-
not yet assessed
-
Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry ↗British Journal of Haematology · 2022 · PMID 36335984not yet assessed
-
Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals ↗Blood Advances · 2022 · PMID 35561316not yet assessed
-
Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs ↗Blood Advances · 2022 · PMID 35042235not yet assessed
-
Deconvolution of the hematopoietic stem cell microenvironment reveals a high degree of specialization and conservationiScience · 2022 · PMID 35494238L1 60/100
-
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis ↗The Journal of Allergy and Clinical Immunology In Practice · 2022 · PMID 36403897not yet assessed
-
not yet assessed
-
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms ↗Blood · 2022 · PMID 35100354not yet assessed
-
Haematological malignancies in relatives of patients affected with myeloproliferative neoplasms ↗eJHaem · 2022 · PMID 35846061not yet assessed
-
not yet assessed
-
P741: DDX41 MUTATIONS DEFINE A UNIQUE SUBTYPE OF MYELOID NEOPLASMS. ↗HemaSphere · 2022not yet assessed
-
not yet assessed
-
Clonal Trajectories and Therapeutic Targeting of High-Risk SF3B1-Mutant Myelodysplastic Syndromes ↗Blood · 2022not yet assessed
-
Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis ↗Communications Biology · 2022 · PMID 36482178not yet assessed
-
Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns ↗Nature Communications · 2022 · PMID 36481665not yet assessed
-
Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes ↗Nature Communications · 2022 · PMID 36481610not yet assessed
-
Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours ↗Nature Communications · 2022 · PMID 36481612not yet assessed
-
not yet assessed
-
Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases ↗Blood · 2022not yet assessed
-
not yet assessed
-
Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer ↗Nature Communications · 2022 · PMID 36481818not yet assessed
-
Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations ↗Nature Communications · 2022 · PMID 36481652not yet assessed
-
Author Correction: Integrative pathway enrichment analysis of multivariate omics data ↗Nature Communications · 2022 · PMID 36481658not yet assessed
-
Author Correction: Inferring structural variant cancer cell fraction ↗Nature Communications · 2022 · PMID 36481724not yet assessed
-
Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower ↗Nature Communications · 2022 · PMID 36481739not yet assessed
-
Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig ↗Nature Communications · 2022 · PMID 36482170not yet assessed
-
Relationship between clone metrics and clinical outcome in clonal cytopenia ↗Blood · 2021 · PMID 34255818not yet assessed
-
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy ↗Haematologica · 2021 · PMID 34233450not yet assessed
-
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis ↗Leukemia · 2021 · PMID 34545185not yet assessed
-
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease ↗Frontiers in Immunology · 2021 · PMID 33732266not yet assessed
-
ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing ↗Blood Cancer Discovery · 2021 · PMID 34568833not yet assessed
-
Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia ↗Blood · 2021 · PMID 34166485not yet assessed
-
A predictive algorithm using clinical and laboratory parameters may assist in ruling out and in diagnosing MDS ↗Blood Advances · 2021 · PMID 34387647not yet assessed
-
Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers ↗International Journal of Molecular Sciences · 2021 · PMID 34681880not yet assessed
-
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes ↗Blood Advances · 2021 · PMID 34592765not yet assessed
-
Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality ↗Blood Advances · 2021 · PMID 34459888not yet assessed
-
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis ↗Blood Advances · 2021 · PMID 33666652not yet assessed
-
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications ↗Current Opinion in Hematology · 2021 · PMID 34342292not yet assessed
-
EHA Endorsement of the European Guidelines for Myelodysplastic Syndromes, MDS-RIGHT ↗HemaSphere · 2021 · PMID 34476344not yet assessed
-
The EHA Research Roadmap: Malignant Myeloid Diseases ↗HemaSphere · 2021 · PMID 34476345not yet assessed
-
The journey of a thousand miles begins with 1 step ↗Blood · 2021 · PMID 34499156not yet assessed
-
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes ↗Nature Medicine · 2021not yet assessed
-
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes ↗Nature Medicine · 2021 · PMID 33564192not yet assessed
-
not yet assessed
-
Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms ↗Blood · 2021not yet assessed
-
Deep deconvolution of the hematopoietic stem cell regulatory microenvironment reveals a high degree of specialization and conservation between mouse and human ↗bioRxiv (Cold Spring Harbor Laboratory) · 2021not yet assessed
-
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS (vol 136, pg 157, 2020)Blood · 2021not yet assessed
-
Topic: AS02-Epidemiology ↗Leukemia Research · 2021not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Deep Deconvolution of the Hematopoietic Stem Cell Regulatory Microenvironment Reveals a High Degree of Specialization and Conservation Between Mouse and Human ↗SSRN Electronic Journal · 2021not yet assessed
-
Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution ↗Leukemia Research · 2021not yet assessed
-
The repertoire of mutational signatures in human cancer ↗Nature · 2020 · PMID 32025018not yet assessed
-
Pan-cancer analysis of whole genomes ↗Nature · 2020 · PMID 32025007not yet assessed
-
The evolutionary history of 2,658 cancers ↗Nature · 2020 · PMID 32025013not yet assessed
-
Patterns of somatic structural variation in human cancer genomes ↗Nature · 2020 · PMID 32025012not yet assessed
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing ↗Nature Genetics · 2020 · PMID 32025003not yet assessed
-
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes ↗Nature · 2020 · PMID 32025015not yet assessed
-
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes ↗Nature Medicine · 2020 · PMID 32747829not yet assessed
-
Comprehensive molecular characterization of mitochondrial genomes in human cancers ↗Nature Genetics · 2020 · PMID 32024997not yet assessed
-
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition ↗Nature Genetics · 2020 · PMID 32024998not yet assessed
-
Genomic basis for RNA alterations in cancer ↗Nature · 2020 · PMID 32025019not yet assessed
-
The landscape of viral associations in human cancers ↗Nature Genetics · 2020 · PMID 32025001not yet assessed
-
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer ↗Nature Genetics · 2020 · PMID 32024999not yet assessed
-
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS ↗Blood · 2020 · PMID 32347921not yet assessed
-
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns ↗Nature Communications · 2020 · PMID 32024849not yet assessed
-
Integrative pathway enrichment analysis of multivariate omics data ↗Nature Communications · 2020 · PMID 32024846not yet assessed
-
Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis ↗Communications Biology · 2020 · PMID 32024996not yet assessed
-
Divergent mutational processes distinguish hypoxic and normoxic tumours ↗Nature Communications · 2020 · PMID 32024819not yet assessed
-
Genomic footprints of activated telomere maintenance mechanisms in cancer ↗Nature Communications · 2020 · PMID 32024817not yet assessed
-
Sex differences in oncogenic mutational processes ↗Nature Communications · 2020 · PMID 32859912not yet assessed
-
Pathway and network analysis of more than 2500 whole cancer genomes ↗Nature Communications · 2020 · PMID 32024854not yet assessed
-
Combined Cohesin–RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes ↗Cancer Discovery · 2020 · PMID 32249213not yet assessed
-
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification ↗Allergy · 2020 · PMID 32108361not yet assessed
-
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations ↗Nature Communications · 2020 · PMID 32024823not yet assessed
-
Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals ↗Blood · 2020 · PMID 32243522not yet assessed
-
Combined burden and functional impact tests for cancer driver discovery using DriverPower ↗Nature Communications · 2020 · PMID 32024818not yet assessed
-
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective ↗Haematologica · 2020 · PMID 33054132not yet assessed
-
Inferring structural variant cancer cell fraction ↗Nature Communications · 2020 · PMID 32024845not yet assessed
-
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples ↗Nature Communications · 2020 · PMID 32958763not yet assessed
-
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig ↗Nature Communications · 2020 · PMID 32024834not yet assessed
-
Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome ↗Nature Cell Biology · 2020 · PMID 32251398not yet assessed
-
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis ↗Theranostics · 2020 · PMID 33391475not yet assessed
-
Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia ↗Proceedings of the National Academy of Sciences · 2020 · PMID 32424097not yet assessed
-
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms ↗Leukemia · 2020 · PMID 33349666not yet assessed
-
Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease ↗Accounts of Chemical Research · 2020 · PMID 33317262not yet assessed
-
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome ↗Leukemia · 2020 · PMID 32948844not yet assessed
-
EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies ↗ESMO Open · 2020 · PMID 31958292not yet assessed
-
Guideline-based indicators for adult patients with myelodysplastic syndromes ↗Blood Advances · 2020 · PMID 32841339not yet assessed
-
Butler enables rapid cloud-based analysis of thousands of human genomes ↗Nature Biotechnology · 2020 · PMID 32024987not yet assessed
-
A continuous-time Markov model approach for modeling myelodysplastic syndromes progression from cross-sectional data ↗Journal of Biomedical Informatics · 2020 · PMID 32113003not yet assessed
-
A Personalized Clinical-Decision Tool to Improve the Diagnostic Accuracy of Myelodysplastic Syndromes ↗Blood · 2020not yet assessed
-
Multicenter Next-Generation Sequencing Studies between Theory and Practice ↗Journal of Molecular Diagnostics · 2020 · PMID 33359455not yet assessed
-
Genotype-Phenotype Correlations in Patients with Myeloid Malignancies Using Explainable Artificial Intelligence ↗Blood · 2020not yet assessed
-
not yet assessed
-
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples ↗Nature Communications · 2020 · PMID 33257764not yet assessed
-
3108 – MOLECULAR MECHANISMS OF LENALIDOMIDE RESISTANCE IN DEL(5Q) MYELODYSPLASTIC SYNDROMES ↗Experimental Hematology · 2020not yet assessed
-
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups ↗Leukemia · 2019 · PMID 30635634not yet assessed
-
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants ↗Blood Advances · 2019 · PMID 31648317not yet assessed
-
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions ↗Haematologica · 2019 · PMID 31048353not yet assessed
-
CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice ↗American Society of Clinical Oncology Educational Book · 2019 · PMID 31099654not yet assessed
-
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome ↗Leukemia · 2019 · PMID 30940907not yet assessed
-
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes ↗Haematologica · 2019 · PMID 31171638not yet assessed
-
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry ↗Leukemia · 2019 · PMID 31740811not yet assessed
-
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry ↗Haematologica · 2019 · PMID 31278207not yet assessed
-
Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations ↗Biomolecules · 2019 · PMID 31640290not yet assessed
-
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes ↗American Journal of Hematology · 2019 · PMID 31680297not yet assessed
-
A Rule-Based Expert System for Automatic Implementation of Somatic Variant Clinical Interpretation Guidelines ↗Lecture notes in computer science · 2019not yet assessed
-
TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes ↗Blood · 2019not yet assessed
-
Implications of TP53 Allelic State for Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes ↗bioRxiv (Cold Spring Harbor Laboratory) · 2019not yet assessed
-
not yet assessed
-
CLINICAL AND MOLECULAR CHARACTERISTICS OF SRSF2-MUTATED NEOPLASMS ↗HemaSphere · 2019not yet assessed
-
S135 NGS‐BASED COPY‐NUMBER ANALYSIS IN MORE THAN 2,000 PATIENTS WITH MYELOID NEOPLASMS ↗HemaSphere · 2019not yet assessed
-
Integrated Analysis of Copy-Number Alterations and Gene Mutations in 2,000 Patients with Myeloid Neoplasms ↗Blood · 2019not yet assessed
-
not yet assessed
-
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations ↗Blood · 2018 · PMID 29930011not yet assessed
-
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia ↗Nature Communications · 2018 · PMID 30194306not yet assessed
-
Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials ↗Blood · 2018 · PMID 30404811not yet assessed
-
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults ↗HemaSphere · 2018 · PMID 31723789not yet assessed
-
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study ↗Leukemia · 2018 · PMID 29572506not yet assessed
-
Infection perturbs Bach2- and Bach1-dependent erythroid lineage ‘choice’ to cause anemia ↗Nature Immunology · 2018 · PMID 30250186not yet assessed
-
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives ↗The Journal of Allergy and Clinical Immunology In Practice · 2018 · PMID 30416055not yet assessed
-
appreci8: a pipeline for precise variant calling integrating 8 tools ↗Bioinformatics · 2018 · PMID 29945233not yet assessed
-
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes ↗Blood Advances · 2018 · PMID 30126931not yet assessed
-
Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS ↗Leukemia Research · 2018 · PMID 30219650not yet assessed
-
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS ↗Leukemia Research · 2018 · PMID 29407183not yet assessed
-
Cannibalism by erythroleukaemic blasts ↗British Journal of Haematology · 2018 · PMID 29797401not yet assessed
-
not yet assessed
-
Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death ↗Blood · 2018not yet assessed
-
not yet assessed
-
Genome-Wide Analysis of Non-Coding Alterations in Pan-Myeloid Cancers Using Whole Genome Sequencing ↗Blood · 2018not yet assessed
-
Clinical significance of somatic mutation in unexplained blood cytopenia ↗Blood · 2017 · PMID 28424163not yet assessed
-
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel ↗Blood · 2017 · PMID 28096091not yet assessed
-
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions ↗Oncotarget · 2017 · PMID 29088721not yet assessed
-
Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance ↗Haematologica · 2017 · PMID 28983055not yet assessed
-
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes ↗Journal of Clinical Investigation · 2017 · PMID 28436936not yet assessed
-
Gene expression and risk of leukemic transformation in myelodysplasia ↗Blood · 2017 · PMID 29097382not yet assessed
-
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System ↗Leukemia · 2017 · PMID 28321120not yet assessed
-
Recognition of familial myeloid neoplasia in adults ↗Seminars in Hematology · 2017 · PMID 28637618not yet assessed
-
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes ↗Journal of Clinical Investigation · 2017not yet assessed
-
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance ↗Annals of Hematology · 2017 · PMID 28526957not yet assessed
-
IDENTIFICATION OF ABERRANTLY SPLICED GENES AND DEREGULATED PATHWAYS/GENE ONTOLOGY THEMES IN MYELODYSPLASTIC SYNDROME PATIENTS WITH SPLICING FACTOR GENE MUTATIONSHaematologica · 2017not yet assessed
-
Hypoplastic Myelodysplastic Syndrome: Clinical, Histopathological and Molecular Characterization ↗Blood · 2017not yet assessed
-
not yet assessed
-
Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. A Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry ↗Leukemia Research · 2017not yet assessed
-
Identification of Aberrant Splicing Events in Myelodysplastic Syndrome Patients with Splicing Factor Gene Mutations ↗Leukemia Research · 2017not yet assessed
-
Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry ↗Leukemia Research · 2017not yet assessed
-
Health-Related Quality of Life is Substantially Impaired in Lower-Risk MDS when Compared with Reference Populations and Significantly Affects Overall Survival ↗Leukemia Research · 2017not yet assessed
-
not yet assessed
-
Introduction ↗Seminars in Hematology · 2017 · PMID 28958285not yet assessed
-
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia ↗Blood · 2016 · PMID 27385790not yet assessed
-
Time-dependent changes in mortality and transformation risk in MDS ↗Blood · 2016 · PMID 27335276not yet assessed
-
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes ↗Blood · 2016 · PMID 27535995not yet assessed
-
Erythropoiesis‐stimulating agents significantly delay the onset of a regular transfusion need in nontransfused patients with lower‐risk myelodysplastic syndrome ↗Journal of Internal Medicine · 2016 · PMID 27926979not yet assessed
-
Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts ↗British Journal of Haematology · 2016 · PMID 27391606not yet assessed
-
not yet assessed
-
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndrome ↗Experimental Hematology · 2016 · PMID 27080012not yet assessed
-
Vascular endothelial growth factor overexpression in myelodysplastic syndrome bone marrow cells: biological and clinical implications ↗Leukemia & lymphoma/Leukemia and lymphoma · 2016 · PMID 27897450not yet assessed
-
not yet assessed
-
not yet assessed
-
Predictive Value of Mutation Analysis in the Diagnostic Approach to Patients with Unexplained Cytopenia ↗Blood · 2016not yet assessed
-
not yet assessed
-
Combined DNA and Transcriptome Sequencing Reveals Discrete Subtypes of Myelodysplasia ↗Blood · 2016not yet assessed
-
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts ↗Blood · 2015 · PMID 25957392not yet assessed
-
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes ↗Nature Communications · 2015 · PMID 25574665not yet assessed
-
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults ↗Blood · 2015 · PMID 25624319not yet assessed
-
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM) ↗Leukemia · 2015 · PMID 25721895not yet assessed
-
not yet assessed
-
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms ↗Haematologica · 2015 · PMID 26341525not yet assessed
-
The shadowlands of MDS: idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP) ↗Hematology · 2015 · PMID 26637737not yet assessed
-
Validation of the revised international prognostic scoring system ( IPSS ‐R) in patients with lower‐risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS ( EUMDS ) registry ↗British Journal of Haematology · 2015 · PMID 25907546not yet assessed
-
Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing ↗Hematology · 2015 · PMID 26637696not yet assessed
-
Iron overload‐related heart failure in a patient with transfusion‐dependent myelodysplastic syndrome reversed by intensive combined chelation therapy ↗Clinical Case Reports · 2015 · PMID 26576280not yet assessed
-
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications ↗Current Opinion in Oncology · 2015 · PMID 26352542not yet assessed
-
not yet assessed
-
SF3B1 Mutation Is an Independent Predictor of Parenchymal Iron Overload in Myelodysplastic Syndromes ↗Blood · 2015not yet assessed
-
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo ↗Cancer Cell · 2015not yet assessed
-
not yet assessed
-
not yet assessed
-
51 PROGNOSTIC IMPACT OF TRANSFUSION INTENSITY ON SURVIVAL AND THROMBOCYTOPENIA IN NEWLY DIAGNOSED LOWER-RISK MDS PATIENTS PARTICIPATING IN THE EUROPEAN LEUKEMIANET MDS (EUMDS) REGISTRY ↗Leukemia Research · 2015not yet assessed
-
24 COMPREHENSIVE ANALYSIS OF ALTERNATIVE RNA SPLICING IN MYELODYSPLASTIC SYNDROMES ↗Leukemia Research · 2015not yet assessed
-
not yet assessed
-
not yet assessed
-
High resolution cytogenetic mapping and whole exome sequencingreveal a complx pattern of chromosome 6p aberrations inpatients with myeloid malignancies.2015not yet assessed
-
Prognostic significance of rare single abnormalities in Myelodysplastic SyndromesGRO · 2015not yet assessed
-
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo ↗Cancer Cell · 2014 · PMID 24835589not yet assessed
-
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia ↗Blood · 2014 · PMID 24970933not yet assessed
-
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells ↗Leukemia · 2014 · PMID 25428262not yet assessed
-
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R ↗Blood · 2014 · PMID 24558201not yet assessed
-
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes ↗Leukemia · 2014 · PMID 24935723not yet assessed
-
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia ↗Blood · 2014 · PMID 25343957not yet assessed
-
Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia ↗Haematologica · 2014 · PMID 24425693not yet assessed
-
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms ↗Haematologica · 2014 · PMID 25420280not yet assessed
-
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo ↗Cancer Cell · 2014not yet assessed
-
Should Patients With High-Risk or Transformed Myelodysplastic Syndrome Proceed Directly to Allogeneic Transplant Without Prior Cytoreduction by Remission-Induction Chemotherapy or Hypomethylating Agent Therapy? ↗Clinical Lymphoma Myeloma & Leukemia · 2014 · PMID 25486954not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMESHaematologica · 2014not yet assessed
-
not yet assessed
-
Genetic Determinants of Disease Phenotype and Clinical Outcome in Myelodysplastic Syndromes with Ring Sideroblasts ↗Blood · 2014not yet assessed
-
not yet assessed
-
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms ↗New England Journal of Medicine · 2013 · PMID 24325356not yet assessed
-
Clinical and biological implications of driver mutations in myelodysplastic syndromes ↗Blood · 2013 · PMID 24030381not yet assessed
-
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet ↗Blood · 2013 · PMID 23980065not yet assessed
-
The genetic basis of myelodysplasia and its clinical relevance ↗Blood · 2013 · PMID 24136165not yet assessed
-
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia ↗Blood · 2013 · PMID 23372164not yet assessed
-
Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis ↗Journal of Clinical Oncology · 2013 · PMID 23797000not yet assessed
-
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome ↗American Journal of Hematology · 2013 · PMID 23606215not yet assessed
-
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 ↗Haematologica · 2013 · PMID 23300182not yet assessed
-
Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes ↗Journal of Clinical Oncology · 2013 · PMID 24002510not yet assessed
-
Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups ↗Haematologica · 2013 · PMID 24006407not yet assessed
-
Refractory anemia with ring sideroblasts ↗Best Practice & Research Clinical Haematology · 2013 · PMID 24507814not yet assessed
-
Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2 ↗PLoS ONE · 2013 · PMID 24147083not yet assessed
-
not yet assessed
-
Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors ↗British Journal of Haematology · 2013 · PMID 23573868not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
P-113 Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PM ↗Leukemia Research · 2013not yet assessed
-
O-001 Clinical and biological implications of gene mutations in MDS ↗Leukemia Research · 2013not yet assessed
-
I-009 RARS-T: Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis ↗Leukemia Research · 2013not yet assessed
-
O-027 European distribution of usage and impact on outcome for treatment with erythropoietic stimulating agents within the EUMDS lower-risk registry programme ↗Leukemia Research · 2013not yet assessed
-
not yet assessed
-
Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PMGRO · 2013not yet assessed
-
Revised International Prognostic Scoring System for Myelodysplastic Syndromes ↗Blood · 2012 · PMID 22740453not yet assessed
-
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group ↗Leukemia · 2012 · PMID 22307178not yet assessed
-
Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study ↗Haematologica · 2012 · PMID 22315489not yet assessed
-
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms ↗Blood · 2012 · PMID 23160465not yet assessed
-
Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis ↗Haematologica · 2012 · PMID 22532522not yet assessed
-
Clinical significance of genetic aberrations in secondary acute myeloid leukemia ↗American Journal of Hematology · 2012 · PMID 22887079not yet assessed
-
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group ↗Leukemia & lymphoma/Leukemia and lymphoma · 2012 · PMID 22916713not yet assessed
-
From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging ↗British Journal of Haematology · 2012 · PMID 22571809not yet assessed
-
not yet assessed
-
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool ↗Haematologica · 2012 · PMID 22271887not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Definizione degli aspetti displastici nelle sindromi mielodisplastiche: proposta di un pannello morfologico standardizzato ↗Università degli Studi di Pavia · 2012not yet assessed
-
Syndromes Revised International Prognostic Scoring System for Myelodysplastic2012not yet assessed
-
not yet assessed
-
SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts ↗New England Journal of Medicine · 2011 · PMID 21995386not yet assessed
-
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms ↗Blood · 2011 · PMID 21998214not yet assessed
-
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) ↗Haematologica · 2011 · PMID 21659359not yet assessed
-
Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies ↗American Journal of Hematology · 2011 · PMID 22190018not yet assessed
-
Classification and Prognostic Evaluation of Myelodysplastic Syndromes ↗Seminars in Oncology · 2011 · PMID 21943669not yet assessed
-
Myelodysplastic syndromes with bone marrow fibrosis ↗Haematologica · 2011 · PMID 21282718not yet assessed
-
Myelodysplastic/Myeloproliferative Neoplasms ↗Hematology · 2011 · PMID 22160044not yet assessed
-
137 Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group ↗Leukemia Research · 2011not yet assessed
-
not yet assessed
-
14 Revised International Prognostic Scoring System (IPSS-R), developed by the International Prognostic Working Group for Prognosis in MDS (IWG-PM) ↗Leukemia Research · 2011not yet assessed
-
not yet assessed
-
Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem‐cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo ↗American Journal of Hematology · 2011 · PMID 21809371not yet assessed
-
not yet assessed
-
The relevance of transfusion‐dependency in the prognostic assessment of patients with myeloid neoplasms ↗American Journal of Hematology · 2011 · PMID 21351118not yet assessed
-
Marked down‐regulation of nucleophosmin‐1 is associated with advanced del(5q) myelodysplastic syndrome ↗British Journal of Haematology · 2011 · PMID 21492127not yet assessed
-
not yet assessed
-
7 Management of 1000 patients with low- and intermediate-1 risk myelodysplastic syndromes in the European LeukemiaNet MDS Registry ↗Leukemia Research · 2011not yet assessed
-
Identification of Novel Somatic Mutations in SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts and Other Common Cancers ↗European Journal of Cancer · 2011not yet assessed
-
50 The identification of novel somatic mutations in MDS by whole exome sequencing ↗Leukemia Research · 2011not yet assessed
-
MULTICENTRE VALIDATION OF A REPRODUCIBLE FLOW CYTOMETRIC SCORE FOR THE DIAGNOSIS OF LOWRISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A EUROPEAN LeukemiaNET STUDYCytometry Part A · 2011not yet assessed
-
34 Health-related quality of life in low-risk MDS patients from the European LeukemiaNet Registry: Correlation with age, gender and decreased survival ↗Leukemia Research · 2011not yet assessed
-
Effetti della sovraespressione di ferritina mitocondriale in precursori eritroidi normali ↗Università degli Studi di Pavia · 2011not yet assessed
-
24 New prognostic scores ↗Leukemia Research · 2011not yet assessed
-
71 Pathogenetic and prognostic role of vascular endothelial growth factor in myelodysplastic syndromes ↗Leukemia Research · 2011not yet assessed
-
Distinct genetic lesions drive leuekmogenesis in secondaryacute myeloid leukemia2011not yet assessed
-
not yet assessed
-
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells ↗Leukemia · 2010 · PMID 20220779not yet assessed
-
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia ↗Leukemia · 2010 · PMID 20182461not yet assessed
-
Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome ↗Haematologica · 2010 · PMID 21134982not yet assessed
-
Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS ↗Haematologica · 2010 · PMID 20884708not yet assessed
-
Prognostic Classification and Risk Assessment in Myelodysplastic Syndromes ↗Hematology/Oncology Clinics of North America · 2010 · PMID 20359637not yet assessed
-
Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G‐CSF ↗British Journal of Haematology · 2010 · PMID 20408843not yet assessed
-
not yet assessed
-
Sequence Variations in Mitochondrial Ferritin: Distribution in Healthy Controls and Different Types of Patients ↗Genetic Testing and Molecular Biomarkers · 2010 · PMID 20939738not yet assessed
-
Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010 ↗Leukemia Research · 2010 · PMID 21036397not yet assessed
-
not yet assessed
-
not yet assessed
-
Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts ↗Blood · 2010not yet assessed
-
not yet assessed
-
not yet assessed
-
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes ↗Haematologica · 2009 · PMID 19546437not yet assessed
-
Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study ↗Haematologica · 2009 · PMID 19546439not yet assessed
-
Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study ↗Haematologica · 2009 · PMID 19903678not yet assessed
-
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis ↗Blood · 2009 · PMID 19692701not yet assessed
-
Clinical relevance of extra-hematologic comorbidity in the management of patients with myelodysplastic syndrome ↗Haematologica · 2009 · PMID 19407314not yet assessed
-
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes ↗British Journal of Haematology · 2009 · PMID 19438482not yet assessed
-
Red Bood Cell Transfusion Therapy and Iron Chelation in Patients With Myelodysplastic Syndromes ↗Clinical Lymphoma & Myeloma · 2009 · PMID 19778858not yet assessed
-
not yet assessed
-
not yet assessed
-
The Effects of Mitochondrial Ferritin Expression in Normal and Sideroblastic Erythropoiesis. ↗Blood · 2009not yet assessed
-
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells. ↗Blood · 2009not yet assessed
-
NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING2009not yet assessed
-
P015 European LeukemiaNet registry programme for low/INT-1 IPSS score myelodysplastic syndromes ↗Leukemia Research · 2009not yet assessed
-
YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets ↗Leukemia Research · 2009not yet assessed
-
11 Real-time prognostic evaluation in MDS ↗Leukemia Research · 2009not yet assessed
-
P036 Diagnostic utility of flow cytometry in myelodysplastic syndromes lacking conventional diagnostic markers: a prospective validation study ↗Leukemia Research · 2009not yet assessed
-
not yet assessed
-
Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome ↗Journal of Clinical Oncology · 2008 · PMID 18559873not yet assessed
-
Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes ↗Journal of Clinical Oncology · 2008 · PMID 19103730not yet assessed
-
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) ↗Blood · 2008 · PMID 18497321not yet assessed
-
The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts ↗PLoS ONE · 2008 · PMID 18398482not yet assessed
-
Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes ↗Hematology · 2008 · PMID 19074076not yet assessed
-
Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal‐ and translation‐related genes ↗British Journal of Haematology · 2008 · PMID 18477045not yet assessed
-
Myelodysplastic Syndromes: Diagnosis and Staging ↗Cancer Control · 2008 · PMID 18813205not yet assessed
-
Supportive Care and Use of Hematopoietic Growth Factors in Myelodysplastic Syndromes ↗Seminars in Hematology · 2008 · PMID 18179965not yet assessed
-
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays ↗Haematologica · 2008 · PMID 18508791not yet assessed
-
Supportive care, growth factors, and new therapies in myelodysplastic syndromes ↗Blood Reviews · 2008 · PMID 18068281not yet assessed
-
Erythroid Activity, Transfusion Iron Overload, and Hepcidin Levels in Patients with Myelodysplastic Syndrome ↗Blood · 2008not yet assessed
-
not yet assessed
-
Prognostic relevance of anemia in myelodysplastic syndromes ↗American Journal of Hematology · 2008 · PMID 18756539not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
In Reply ↗Journal of Clinical Oncology · 2008not yet assessed
-
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes ↗Journal of Clinical Oncology · 2007 · PMID 17687155not yet assessed
-
Gene expression profiling of CD34+ cells in patients with the 5q− syndrome ↗British Journal of Haematology · 2007 · PMID 17916100not yet assessed
-
Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes ↗Leukemia Research · 2007 · PMID 18037415not yet assessed
-
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes ↗Leukemia · 2007 · PMID 18094717not yet assessed
-
Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes ↗European Journal Of Haematology · 2007 · PMID 18081721not yet assessed
-
Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: evidence of a different adaptive strategy? ↗European Journal of Applied Physiology · 2007 · PMID 17206440not yet assessed
-
not yet assessed
-
Myelodysplastic/myeloproliferative disorders ↗Haematologica · 2007not yet assessed
-
23 WPSS, a dynamic prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes ↗Leukemia Research · 2007not yet assessed
-
P136 Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need ↗Leukemia Research · 2007not yet assessed
-
C023 Expression profiling of CD34+ cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes ↗Leukemia Research · 2007not yet assessed
-
not yet assessed
-
C019 Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del (5q) using high-density SNP arrays ↗Leukemia Research · 2007not yet assessed
-
P080 Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome ↗Leukemia Research · 2007not yet assessed
-
OP19 Transfusion dependence and iron overload and prognostic modelling of MDS ↗Leukemia Research · 2007not yet assessed
-
S06 Clinical relevance and treatment of transfusional iron overload in myelodysplastic syndromes ↗Leukemia Research · 2007not yet assessed
-
P023 Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukemias and myelodysplastic syndromes ↗Leukemia Research · 2007not yet assessed
-
24 Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndrome ↗Leukemia Research · 2007not yet assessed
-
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome ↗Leukemia · 2006 · PMID 16498394not yet assessed
-
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia ↗European Journal Of Haematology · 2006 · PMID 16529600not yet assessed
-
Treatment with Erythropoietin and G-CSF Improves Survival in MDS Patients with Low Transfusion Need. ↗Blood · 2006not yet assessed
-
not yet assessed
-
Predicting survival and leukemic evolution in patients with myelodysplastic syndrome. ↗PubMed · 2006 · PMID 17145593not yet assessed
-
Novel homeobox gene recombination in T-cell acute lymphoblastic leukemia. ↗PubMed · 2006 · PMID 16531247not yet assessed
-
Granulocyte JAK2 (V617F) Mutation Status in Myeloid Neoplasms with Ringed Sideroblasts. ↗Blood · 2006not yet assessed
-
SI33 Implications and Management of Iron Overload in Myelodysplastic Syndromes ↗Transfusion Medicine · 2006not yet assessed
-
Effects of heparins on hemostatic properties of vascular endothelium. ↗PubMed · 2006 · PMID 16461295not yet assessed
-
not yet assessed
-
High-Resolution Genomic Profiling of Myelodysplasia (MDS) by Microarray Comparative Genomic Hybridization (CGH). ↗Blood · 2006not yet assessed
-
Pharmacokinetics and hemostatic efficacy of solvent/detergent plasma in recessively inherited coagulation disordersHaematologica · 2006not yet assessed
-
Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making ↗Journal of Clinical Oncology · 2005 · PMID 16186598not yet assessed
-
Myelodysplastic Syndromes — Coping with Ineffective Hematopoiesis ↗New England Journal of Medicine · 2005 · PMID 15703418not yet assessed
-
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders ↗Blood · 2005 · PMID 16373657not yet assessed
-
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome ↗Leukemia · 2005 · PMID 15789068not yet assessed
-
Genetic and clinical heterogeneity of ferroportin disease ↗British Journal of Haematology · 2005 · PMID 16351644not yet assessed
-
A WHO Classification-Based Prognostic Scoring System (WPSS) for Predicting Survival in Myelodysplastic Syndromes. ↗Blood · 2005not yet assessed
-
Myelodysplastic/myeloproliferative disorders. ↗PubMed · 2005 · PMID 15644305not yet assessed
-
Detection of minimal residual disease in acute lymphoblastic leukemiaHaematologica · 2005not yet assessed
-
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia ↗Leukemia · 2005 · PMID 15744342not yet assessed
-
not yet assessed
-
not yet assessed
-
Natural anti-Gal antibodies Eth a tool for designing novel tumor cell vaccinesDOAJ (DOAJ: Directory of Open Access Journals) · 2005not yet assessed
-
P-14 Demographic and disease-related prognostic factors in myelodysplastic syndromes classified according to who criteria ↗Leukemia Research · 2005not yet assessed
-
P-37 Flow cytometric analysis of cytosolic and mitochondrial ferritins in immature red blood cells from patients with myelodysplastic syndrome ↗Leukemia Research · 2005not yet assessed
-
Simian virus 40 and lymphoproliferative disorder. ↗PubMed · 2005 · PMID 16330424not yet assessed
-
Risk factors for Gram-negative infections in neutropenic patients. ↗PubMed · 2005 · PMID 16079097not yet assessed
-
Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia. ↗PubMed · 2005 · PMID 16219554not yet assessed
-
not yet assessed
-
Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)Experimental Hematology · 2005not yet assessed
-
not yet assessed
-
Clinical significance of neutrophil CD177 mRNA expression in Ph‐negative chronic myeloproliferative disorders ↗British Journal of Haematology · 2004 · PMID 15327515not yet assessed
-
Cerebral vasoreactivity in Andeans and headache at sea level ↗Journal of the Neurological Sciences · 2004 · PMID 15050445not yet assessed
-
Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies ↗Bone Marrow Transplantation · 2004 · PMID 15516936not yet assessed
-
Hypereosinophilic syndrome and cyclic oscillations in blood cell counts. A clonal disorder of hematopoiesis originating in a pluripotent stem cell. ↗PubMed · 2004 · PMID 15075087not yet assessed
-
Flow Cytometry Evaluation of Erythroid Dysplasia in Patients with Myelodysplastic Syndrome. ↗Blood · 2004not yet assessed
-
Evidence of Polyclonal Hematopoiesis in a Large Proportion of Patients with Low-Risk Myelodysplastic Syndrome. ↗Blood · 2004not yet assessed
-
Hematologic passport for athletes competing in endurance sports: a feasibility study. ↗PubMed · 2003 · PMID 12745277not yet assessed
-
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders. ↗PubMed · 2003 · PMID 14555308not yet assessed
-
Ventilation, Autonomic Function, Sleep and Erythropoietin ↗Advances in experimental medicine and biology · 2003not yet assessed
-
Ventilation, autonomic function, sleep and erythropoietin. Chronic mountain sickness of Andean natives. ↗PubMed · 2003 · PMID 14713121not yet assessed
-
Dendritic cell recovery after allogeneic stem‐cell transplantation in acute leukemia: correlations with clinical and transplant characteristics ↗European Journal Of Haematology · 2003 · PMID 14962258not yet assessed
-
Gene expression in the Andes; relevance to neurology at sea level ↗Journal of the Neurological Sciences · 2003 · PMID 12614929not yet assessed
-
VENTILATION, AUTONOMIC FUNCTION, SLEEPAND ERYTHROPOIETIN Chronic mountain sickness ofAndean natives2003not yet assessed
-
Peripheral arterial vascular function at altitude: sea-level natives versus Himalayan high-altitude natives ↗Journal of Hypertension · 2001 · PMID 11212963not yet assessed
-
Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant ↗Annals of Hematology · 2001 · PMID 11669300not yet assessed
-
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies ↗Bone Marrow Transplantation · 2000 · PMID 10673703not yet assessed
-
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse ↗British Journal of Haematology · 2000 · PMID 10970133not yet assessed
-
High incidence of symptomatic cytomegalovirus infection in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation ↗Blood · 2000 · PMID 10939798not yet assessed
-
not yet assessed
-
Cytogenetic and FISH analysis in five patients with hypoplastic bone marrow ↗Leukemia · 2000 · PMID 10914562not yet assessed
-
Effects of breathing control on cardiocirculatory modulation in Caucasian lowlanders and Himalayan Sherpas ↗European Journal of Applied Physiology · 2000 · PMID 11192053not yet assessed
-
Trisomy 11 and a Complex t(11;11;22) in a Patient with Acute Myelomonocytic Leukemia (AML-M4) Following Myelodysplasia (MDS) ↗Cancer Genetics and Cytogenetics · 2000 · PMID 10640142not yet assessed
-
Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases ↗Bone Marrow Transplantation · 1999 · PMID 10217182not yet assessed
-
Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation ↗Bone Marrow Transplantation · 1999 · PMID 10217192not yet assessed
-
A novel t(Y;11) translocation with MLL gene rearrangement in a case of acute myelomonocytic leukemia (AML-M4) ↗Leukemia · 1999 · PMID 10086743not yet assessed
-
Fournier’s gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantation ↗Bone Marrow Transplantation · 1998 · PMID 9849702not yet assessed
-
A Complex Translocation (5;7) in a Patient with Acute Nonlymphocytic Leukemia Evolved from a Myelodysplastic Syndrome ↗Cancer Genetics and Cytogenetics · 1998 · PMID 9723039not yet assessed
-
Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? ↗PubMed · 1997 · PMID 9369439not yet assessed
-
201 Cytogenetics to monitor disease outcome after allo-BMT in patients with myelodysplastic syndrome (MDS) ↗Leukemia Research · 1997not yet assessed
-
122 Chromosome 5Q31-specific DNA probe to detect intertitial long arm deletions of chromosome ↗Leukemia Research · 1997not yet assessed
-
Is FISH more effective than cytogenetics in detecting chromosome 5 abnormalities in MDS/ANLL?Experimental Hematology · 1997not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Malcovati L” paper on PubMed ↗